{"@id":"https://bioecon.ru/technology/dna-replication-stress-targeting/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/dna-replication-stress-targeting/","json":"https://cn.bioecon.ru/api/v1/technology/dna-replication-stress-targeting/index.json"},"id":"dna-replication-stress-targeting","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/gsk/","https://bioecon.ru/companies/kelpinor-as/","https://bioecon.ru/companies/acadian-plant-health/","https://bioecon.ru/companies/bluestem-biosciences/","https://bioecon.ru/companies/global-bioenergies/","https://bioecon.ru/companies/haesin/","https://bioecon.ru/companies/puevit-gmbh/"]},"maturity":7,"name":"针对肿瘤DNA复制应激脆弱性的小分子靶向疗法","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"激酶催化凹槽高亲和力竞争性抑制"},{"n":2,"title":"复制叉急性断裂与DNA断裂级联放大"},{"n":3,"title":"生物标志物驱动的合成致死敏感性验证"},{"n":4,"title":"耐药性晚期高度恶性实体瘤体内完全消退"}],"summary":"高选择性催化位点小分子抑制剂靶向DNA复制检验点核心激酶（ATR、CHK1、WEE1、PKMYT1），特异性利用MYC或CCNE1原癌基因过度扩增所诱发的高内源性复制应激，诱发恶性肿瘤细胞复制叉灾难性崩溃与合成致死性有丝分裂灾难。","url":"/technology/dna-replication-stress-targeting/","verified":"2026-11-22"}